CONMED Corp — Director's Dealing 2015

Apr 1, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2015-03-31

Reporting Person: SHALLISH ROBERT D JR (EVP, Finance, CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-03-31	Common Stock	M	1200	—	Acquired	55076	Direct
2015-03-31	Common Stock	F	433	$50.49	Disposed	54643	Direct
2015-03-31	Common Stock	M	2400	—	Acquired	57043	Direct
2015-03-31	Common Stock	F	866	$50.49	Disposed	56177	Direct
2015-03-31	Common Stock	M	3600	—	Acquired	59777	Direct
2015-03-31	Common Stock	F	1299	$50.49	Disposed	58478	Direct
2015-03-31	Common Stock	M	5600	—	Acquired	64078	Direct
2015-03-31	Common Stock	F	2020	$50.49	Disposed	62058	Direct
2015-03-31	Common Stock	M	4550	—	Acquired	66608	Direct
2015-03-31	Common Stock	F	1642	$50.49	Disposed	64966	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-03-31	Rsus (restricted Stock Units)	$0	M	1200	Disposed	2020-06-01	Common Stock (1200)	Direct
2015-03-31	Rsus (restricted Stock Units)	$0	M	2400	Disposed	2021-06-01	Common Stock (2400)	Direct
2015-03-31	Rsus (restricted Stock Units)	$0	M	3600	Disposed	2022-06-01	Common Stock (3600)	Direct
2015-03-31	Rsus (restricted Stock Units)	$0	M	5600	Disposed	2023-06-01	Common Stock (5600)	Direct
2015-03-31	Rsus (restricted Stock Units)	$0	M	4550	Disposed	2024-06-01	Common Stock (4550)	Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date.